ALICIA SETTLE: Open Payments
NPI 1922461995 · FOLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,751 in 79 payments from 30 companies in 2025. Trend: 2023 $1,264 · 2024 $1,494 · 2025 $1,751
Food & beverage: $1,652Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $198 |
| Merck Sharp & Dohme LLC | 6 | $135 |
| Janssen Biotech, Inc. | 3 | $133 |
| Celgene Corporation | 4 | $107 |
| Regeneron Healthcare Solutions, Inc. | 4 | $101 |
| Genentech USA, Inc. | 4 | $89 |
| E.R. Squibb & Sons, L.L.C. | 5 | $84 |
| Lilly USA, LLC | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 5 | $81 |
| PharmaEssentia USA Corporation | 3 | $79 |
Products named: KEYTRUDA, DARZALEX, REBLOZYL, OPDIVO, SCEMBLIX, ENHERTU, LIBTAYO, BESREMI.
Industry payments across AL — which companies pay providers there.
